Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. [electronic resource]
Producer: 20120120Description: 191-5 p. digitalISSN:- 1872-7972
- Animals
- Anti-Inflammatory Agents
- Antigens, Nuclear -- metabolism
- Antimetabolites
- Blood-Brain Barrier -- drug effects
- Bromodeoxyuridine
- Cell Differentiation -- drug effects
- Cell Proliferation -- drug effects
- Female
- Flow Cytometry
- Inflammation -- drug therapy
- Intermediate Filament Proteins -- metabolism
- Movement -- physiology
- NF-kappa B -- biosynthesis
- Nerve Tissue Proteins -- metabolism
- Nestin
- Neural Stem Cells -- drug effects
- PPAR gamma -- agonists
- Rats
- Rats, Sprague-Dawley
- Recovery of Function -- physiology
- Rosiglitazone
- Spinal Cord Injuries -- drug therapy
- Thiazolidinediones -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.